| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.27 | 1e-14 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-14 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.23 | 1e-12 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-11 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-11 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-10 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-10 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-10 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |